Nakul Satyanarayan Chandak
About Nakul Satyanarayan Chandak
Data last updated:
Nakul Satyanarayan Chandak has 26 years in corporate governance. Holds Director and Designated Partner roles. Currently with 7 companies, including Satyam Mats Limited and Mangal Medi-Centre. Formerly with 1 company, such as Metro Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹16.33 Cr; the largest is Satyam Nxtgen Industries Private Limited at ₹10.45 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Satyam Nxtgen Industries Private Limited U27200MH1988PTC048841 | Director | 01 Dec 2008 | 1988 | ₹10.45 Cr (FY 2025) | Active |
 Mangal Medi-Centre U85110MH2003NPL139370 | Director | 27 Feb 2003 | 2003 | ₹3.73 Cr (FY 2024) | Active |
| Satyam Mats Limited U24211MH1998PLC115379 | Director | 02 Dec 1999 | 1998 | ₹2.16 Cr (FY 2025) | Active |
| Mangalam Polywoven Private Limited U74120MH2011PTC224004 | Director | 17 Nov 2011 | 2011 | ₹0.00 Cr (FY 2025) | Active |
| Satyam Knowledge Hub Llp ACB-4509 | Designated Partner | 01 Jun 2023 | 2023 | – | Active |
| Shubhkamna Gharkul Llp ABB-7999 | Designated Partner | 20 Jul 2022 | 2022 | – | Active |
| Mangal Life Care Private Limited U85100MH2014PTC255324 | Director | 29 May 2014 | 2014 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Metro Biotech Private Limited U24124MH2001PTC130696 | Director | 01 Jan 2003 | 2001 | ₹0.05 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nakul Satyanarayan Chandak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nakul Satyanarayan Chandak
Nakul Satyanarayan Chandak has 26 years in corporate governance. Holds Director and Designated Partner roles. Currently with 7 companies, including Satyam Mats Limited and Mangal Medi-Centre. Formerly with 1 company, such as Metro Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The 4 current companies with reported revenue have a combined latest revenue of ₹16.33 Cr; the largest is Satyam Nxtgen Industries Private Limited at ₹10.45 Cr (FY 2025).
Nakul Satyanarayan Chandak is associated with 7 companies as Director and Designated Partner, including Satyam Nxtgen Industries Private Limited (₹10.45 Cr), Mangal Medi-Centre (₹3.73 Cr), Satyam Mats Limited (₹2.16 Cr).
Nakul Satyanarayan Chandak has expertise in General Business, Technology.
Nakul Satyanarayan Chandak has 26 years in corporate governance.
By reported revenue, the largest current company of Nakul Satyanarayan Chandak is Satyam Nxtgen Industries Private Limited, with revenue of ₹10.45 Cr (FY 2025).
The 4 current companies of Nakul Satyanarayan Chandak that report revenue have a combined latest revenue of ₹16.33 Cr.
Nakul Satyanarayan Chandak currently holds positions at 7 companies; the 5 largest by reported revenue are Satyam Nxtgen Industries Private Limited (₹10.45 Cr), Mangal Medi-Centre (₹3.73 Cr), Satyam Mats Limited (₹2.16 Cr), Mangalam Polywoven Private Limited (₹0.00 Cr), Satyam Knowledge Hub Llp.